Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer. (2016)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.2016.67.3061
PubMed Identifier: 27269946
Publication URI: http://europepmc.org/abstract/MED/27269946
Type: Journal Article/Review
Volume: 34
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 25
ISSN: 0732-183X